pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioSpace·3h ago·1 min read
save

Biopharma workers increasingly postpone retirement, poll shows 52% plan to stay longer

Sep 16, 2026·read at BioSpace ↗Neutral

Biopharma professionals are rethinking retirement, with a BioSpace LinkedIn poll indicating that 52% expect to retire later than originally planned. Overall, 63% of respondents said they have changed their retirement timeline.

A similar trend appears in a MyPerfectResume survey of 1,000 U.S. workers, where 48% adjusted their plans and a larger share now anticipate retiring later rather than earlier.

Career coaches attribute the shift to factors such as confidence in future career opportunities, recent layoffs, and personal financial considerations. Those who see a clear path forward in their specialty are more likely to extend their working years.

The findings suggest that retirement expectations among biopharma staff are moving later, reflecting broader workforce dynamics in the industry.

source

This writeup was produced by pharmadog from original reporting by BioSpace.

Original headline: “For many, the retirement goal posts are shifting”

read at BioSpace ↗
856 words · retrieved 2h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
PATH2

related stories

  • May 12Arvinas, Pfizer find new partner for ‘Protac’ breast cancer drugBioPharma Dive
  • May 12Temple Health’s Fox Chase Cancer Center and Labcorp Collaborate to Test Ultra-Sensitive Blood-Based Assay for Early-Stage Lung Cancer Recurrence Riskonclive
  • May 11CSL sinks to nine-year low on revenue warning, $5B write-downEndpoints
  • May 11Precision in motion: Decoding the critical operations behind the logistics of next-generation cell and gene therapiesBioPharma Dive
  • May 11Opinion: AI doctors should be licensed. Here’s a framework to do thatSTAT